{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:45:26Z","timestamp":1761417926572,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":20,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071606797"},{"type":"electronic","value":"9781071606803"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0680-3_4","type":"book-chapter","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T14:23:47Z","timestamp":1594995827000},"page":"37-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design and Application of a Short (16-mer) Locked Nucleic Acid Splice-Switching Oligonucleotide for Dystrophin Production in Duchenne Muscular Dystrophy Myotubes"],"prefix":"10.1007","author":[{"given":"C\u00e9lia","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Carmo-Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,18]]},"reference":[{"issue":"2","key":"4_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/cts.12624","volume":"12","author":"W Yin","year":"2019","unstructured":"Yin W, Rogge M (2019) Targeting RNA: a transformative therapeutic strategy. Clin Transl Sci 12(2):98\u2013112. \nhttps:\/\/doi.org\/10.1111\/cts.12624","journal-title":"Clin Transl Sci"},{"issue":"5","key":"4_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/nat.2017.0682","volume":"27","author":"A Aartsma-Rus","year":"2017","unstructured":"Aartsma-Rus A, Straub V, Hemmings R et al (2017) Development of exon skipping therapies for duchenne muscular dystrophy: a critical review and a perspective on the outstanding issues. Nucleic Acid Ther 27(5):251\u2013259. \nhttps:\/\/doi.org\/10.1089\/nat.2017.0682","journal-title":"Nucleic Acid Ther"},{"issue":"2","key":"4_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/mt.2011.260","volume":"20","author":"MW Lindholm","year":"2012","unstructured":"Lindholm MW, Elm\u00e9n J, Fisker N et al (2012) PCSK9 LNA antisense oligonucleotides induce sustained reduction of LDL cholesterol in nonhuman primates. Mol Ther 20(2):376\u2013381. \nhttps:\/\/doi.org\/10.1038\/mt.2011.260","journal-title":"Mol Ther"},{"issue":"11","key":"4_CR4","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1021\/cr050266u","volume":"107","author":"H Kaur","year":"2007","unstructured":"Kaur H, Babu BR, Maiti S (2007) Perspectives on chemistry and therapeutic applications of locked nucleic acid (LNA). Chem Rev 107(11):4672\u20134697. \nhttps:\/\/doi.org\/10.1021\/cr050266u","journal-title":"Chem Rev"},{"issue":"9","key":"4_CR5","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/nar\/30.9.1911","volume":"30","author":"J Kurreck","year":"2002","unstructured":"Kurreck J, Wyszko E, Gillen C, Erdmann VA (2002) Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res 30(9):1911\u20131918. \nhttps:\/\/doi.org\/10.1093\/nar\/30.9.1911","journal-title":"Nucleic Acids Res"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-407676-1.00002-0","volume":"82","author":"KE Lundin","year":"2013","unstructured":"Lundin KE, H\u00f8jland T, Hansen BR et al (2013) Biological activity and biotechnological aspects of locked nucleic acids. Adv Genet 82:47\u2013107. \nhttps:\/\/doi.org\/10.1016\/B978-0-12-407676-1.00002-0","journal-title":"Adv Genet"},{"issue":"1","key":"4_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/(SICI)1099-1352(200001\/02)13:1<44::AID-JMR486>3.0.CO;2-6","volume":"13","author":"M Petersen","year":"2000","unstructured":"Petersen M, Nielsen CB, Nielsen KE et al (2000) The conformations of locked nucleic acids (LNA). J Mol Recognit 13(1):44\u201353. \nhttps:\/\/doi.org\/10.1002\/(SICI)1099-1352(200001\/02)13:1<44::AID-JMR486>3.0.CO;2-6","journal-title":"J Mol Recognit"},{"issue":"5","key":"4_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010682","volume":"5","author":"N Gupta","year":"2010","unstructured":"Gupta N, Fisker N, Asselin MC et al (2010) A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo. PLoS One 5(5):e10682. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0010682","journal-title":"PLoS One"},{"issue":"1","key":"4_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp841","volume":"38","author":"CA Stein","year":"2010","unstructured":"Stein CA, Hansen JB, Lai J et al (2010) Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res 38(1):e3. \nhttps:\/\/doi.org\/10.1093\/nar\/gkp841","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"4_CR10","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1093\/nar\/30.11.2435","volume":"30","author":"R Crinelli","year":"2002","unstructured":"Crinelli R, Bianchi M, Gentilini L, Magnani M (2002) Design and characterization of decoy oligonucleotides containing locked nucleic acids. Nucleic Acids Res 30(11):2435\u20132443. \nhttps:\/\/doi.org\/10.1093\/nar\/30.11.2435","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"4_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181065","volume":"12","author":"VB Pires","year":"2017","unstructured":"Pires VB, Sim\u00f5es R, Mamchaoui K, Carvalho C, Carmo-Fonseca M (2017) Short (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne muscular dystrophy myotubes. PLoS One 12(7):e0181065. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0181065","journal-title":"PLoS One"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/2044-5040-1-34","volume":"1","author":"K Mamchaoui","year":"2011","unstructured":"Mamchaoui K, Trollet C, Bigot A et al (2011) Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders. Skelet Muscle 1:34. \nhttps:\/\/doi.org\/10.1186\/2044-5040-1-34","journal-title":"Skelet Muscle"},{"issue":"4","key":"4_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ng.786","volume":"43","author":"S Obad","year":"2011","unstructured":"Obad S, dos Santos CO, Petri A et al (2011) Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 43(4):371\u2013380. \nhttps:\/\/doi.org\/10.1038\/ng.786","journal-title":"Nat Genet"},{"issue":"50","key":"4_CR14","doi-asserted-by":"publisher","first-page":"8735","DOI":"10.1016\/S0040-4039(97)10322-7","volume":"38","author":"S Obika","year":"1997","unstructured":"Obika S, Nanbu D, Hari Y et al (1997) Synthesis of 2\u2032-O,4\u2032-C-methyleneuridine and -cytidine. Novel bicyclic nucleosides having a fixed C3, \u2212endo sugar puckering. Tetrahedron Lett 38(50):8735\u20138738. \nhttps:\/\/doi.org\/10.1016\/S0040-4039(97)10322-7","journal-title":"Tetrahedron Lett"},{"key":"4_CR15","doi-asserted-by":"publisher","unstructured":"Singh SK, Nielsen P, Koshkin AA, Wengel J (1998) LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition. Chem Commun:455\u2013456. \nhttps:\/\/doi.org\/10.1039\/A708608C","DOI":"10.1039\/A708608C"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-407676-1.00002-0","volume":"82","author":"KE Lundin","year":"2013","unstructured":"Lundin KE, H\u00f8jland T, Hansen BR et al (2013) Biological activity and biotechnological aspects of locked nucleic acids. Adv Genet 82:47\u2013107. \nhttps:\/\/doi.org\/10.1016\/B978-0-12-407676-1.00002-0","journal-title":"Adv Genet"},{"issue":"10","key":"4_CR17","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/S0968-0896(03)00115-9","volume":"11","author":"K Morita","year":"2003","unstructured":"Morita K, Takagi M, Hasegawa C et al (2003) Synthesis and properties of 2\u2032-O,4\u2032-C-ethylene-bridged nucleic acids (ENA) as effective antisense oligonucleotides. Bioorganic Med Chem 11(10):2211\u20132226. \nhttps:\/\/doi.org\/10.1016\/S0968-0896(03)00115-9","journal-title":"Bioorganic Med Chem"},{"issue":"8","key":"4_CR18","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1093\/nar\/16.8.3209","volume":"16","author":"CA Stein","year":"1988","unstructured":"Stein CA, Subasinghe C, Shinozuka K, Cohen JS (1988) Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res 16(8):3209\u20133221. \nhttps:\/\/doi.org\/10.1093\/nar\/16.8.3209","journal-title":"Nucleic Acids Res"},{"issue":"7189","key":"4_CR19","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nature06783","volume":"452","author":"J Elm\u00e9n","year":"2008","unstructured":"Elm\u00e9n J, Lindow M, Sch\u00fctz S et al (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452(7189):896\u2013899. \nhttps:\/\/doi.org\/10.1038\/nature06783","journal-title":"Nature"},{"issue":"1","key":"4_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/ard.1993.3.53","volume":"3","author":"Q Zhao","year":"1993","unstructured":"Zhao Q, Matson S, Herrera CJ, Fisher E, Yu H, Krieg AM (1993) Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res Dev 3(1):53\u201366. \nhttps:\/\/doi.org\/10.1089\/ard.1993.3.53","journal-title":"Antisense Res Dev"}],"container-title":["Methods in Molecular Biology","RNA-Chromatin Interactions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0680-3_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T14:24:15Z","timestamp":1594995855000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0680-3_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071606797","9781071606803"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0680-3_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"18 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}